secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001493152-25-009075
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals provides unaudited balance sheet as of Jan 31, 2025; cash of $5.36M
--------------------------------------------------------------------------------

- Cash and cash equivalents of $5.36M as of January 31, 2025.
- Total assets of $6.5M, total liabilities of $0.55M.
- Stockholders' equity of $5.95M, accumulated deficit of $238M.
- No revenue or operational update provided; balance sheet only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/0001493152-25-009075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315225009075/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer